Volatile organic compounds (VOCs) are known to be produced by a wide range of micro-organisms and for a number of purposes. Volatile-based microbial inhibition in environments such as soil is well-founded, with numerous antimicrobial VOCs having been identified. Inhibitory VOCs are of interest as microbial control agents, as low concentrations of gaseous VOCs can elicit significant antimicrobial effects. Volatile organic compounds are organic chemicals typically characterized as having low molecular weight, low solubility in water, and high vapour pressure. Consequently, VOCs readily evaporate to the gaseous phase at standard temperature and pressure. This contact-independent antagonism presents unique advantages over traditional, contact-dependent microbial control methods, including increased surface exposure and reduced environmental persistence. This approach has been the focus of our recent research, with positive results suggesting it may be particularly promising for the management of emerging fungal pathogens, such as the causative agents of white-nose syndrome of bats and snake fungal disease, which are difficult or impossible to treat using traditional approaches. Here, we review the history of volatile-based microbial control, discuss recent progress in formulations that mimic naturally antagonistic VOCs, outline the development of a novel treatment device, and highlight areas where further work is needed to successfully deploy VOCs against existing and emerging fungal pathogens.
Introduction
Antibiotics are a class of antimicrobial compounds produced by micro-organisms, which may be further classified by mechanism of action, molecular structure and spectrum of activity, among other properties. While some of the early notable antibiotics to be discovered were the products of fungi (Fleming 1929 ), a great number were later found to be produced by prokaryotic micro-organisms, including many Actinobacteria (Watve et al. 2001; Magarvey et al. 2004) . Another novel class of antimicrobials was discovered following observations of fungal propagules being inhibited from germinating in subterranean environments, termed fungistatic soils (Dobbs and Hinson 1953) . The inhibitory properties of these suppressive soils were later discovered to be caused, in part, by exposure to volatile organic compounds (VOCs) produced by micro-organisms within the substrate (Balis and Kouyeas 1968) . VOCs are organic chemicals typified by properties that facilitate evaporation into the gaseous phase, including low molecular weight, low solubility in water and high vapour pressure. Evaporation of these compounds into the surrounding environment enables micro-organisms to interact and elicit antagonistic effects from a greater distance than could be achieved by direct contact. The ability of antifungal VOCs to negatively impact an organism without having to be directly applied has been termed contact-independent antagonism (Cornelison et al. 2014a) . While the volatile-based fungistatic properties of suppressive soils has since been widely observed across terrestrial environments (Zou et al. 2007) , the inhibitory activities of VOCs are of particular interest due to the ability of these compounds to inhibit microbial growth in dense and diverse ecosystems, from gaseous, contact-independent exposure (Balis and Kouyeas 1968; Voisard et al. 1989; Kerr 1999; Ezra and Strobel 2003; Chuankun et al. 2004; Garbeva et al. 2011) .
Recent work has demonstrated microbially produced VOCs can indeed offer tangible solutions for a number of current fungal pathogens of concern. Weisskopf (2013) discovered that microbially produced VOCs can be applied for the control of phytopathogenic fungi and stimulating crop growth in agricultural contexts. Several emerging fungal pathogens of crops and wildlife have also received attention following increasing incidence and mortality (Fisher et al. 2012) . Further work has shown that using live organisms to produce the VOCs as well as synthetic formulations inspired by natural VOCs can be successful. The ubiquitous soil-dwelling bacterium, Rhodococcus rhodochrous strain DAP 96253, known to possess unique metabolic activities (Pierce et al. 2011) and produce several antagonistic VOCs, inhibited the growth of fungal pathogens, including Pseudogymnoascus destructans, the causative agent of white-nose syndrome (WNS) of bats (Cornelison et al. 2014a (Cornelison et al. , 2014b , and Ophidiomyces ophiodiicola, the causative agent of snake fungal disease (SFD) of reptiles .
The inhibitory effects observed in these studies suggest a potential for VOCs to be utilized in novel ways to combat undesired microbial colonization and infection. These studies prompted an initiative to develop a treatment system capable of distributing VOCs and formulations for wildlife disease management. This new area of research may provide novel methods for controlling infection and contamination, and microbial control in general.
VOCs as antimicrobials
Gaseous VOCs have the propensity to permeate and envelop the objects within the vicinity of an airspace. Micro-organisms exposed to this airspace, either on a host or in the environment, are susceptible to the antimicrobial activities of the VOCs. This contact-independent antagonism has the potential to be utilized to reduce growth, viability, virulence or the environmental load of the target micro-organism. Several microbially produced, antifungal VOCs have been identified from the scientific literature for their potential to be used for microbial control and disease management. Previous studies have demonstrated the ability of these microbially produced VOCs, as well as formulations comprised of several VOCs, to inhibit fungal mycelia growth, conidia viability, pigment production and virulence, when tested in the gaseous phase (Bruce et al. 2003; Fernando et al. 2005; Li et al. 2010; Yuan et al. 2012; Wang et al. 2013; Cornelison et al. 2014a Cornelison et al. , 2016 Wu et al. 2015; Toffano et al. 2017) . However, these studies have not attempted deep probing of soil communities and, therefore, suggest a tremendous untapped potential for the discovery of antimicrobials from fungistatic soil communities.
Synergistic activity
Synergism occurs when the inhibitory effects observed from a formulation comprised of several antimicrobial agents are greater than the additive inhibitions from the same agents exposed singly (Doern 2014) . Synergism may result in several desirable outcomes, including a greater degree of microbial inhibition and reduced toxicity of any single antimicrobial from the formulation (Leh ar et al. 2009 ). Indeed, this synergism has been observed with the inhibition of select fungal pathogens by synthetic VOC formulations of a microbial origin (Cornelison et al. 2014a . However, these positive effects do not negate the possibility of formulations increasing toxicity to the host or other nontarget organisms, and therefore, each formulation should undergo rigorous screening for undesirable effects.
Synergism acts by manipulating the presence and ratio of the constituents of a formulation in order to enhance specific effects. This suggests that synergistic formulations may be engineered to enhance antagonistic effects against spore germination, mycelial growth, and sporulation, as well as potentially reducing virulence or improving the host outcome. If this can be achieved, it would logically follow that there may be an optimum time period for utilizing specific treatment formulations based on seasonality, disease progression, pathogen life cycle, and host metabolic activity, among other factors, in order to elicit optimum effects.
Interestingly, several VOCs have been observed stimulating growth when exposed singly, yet were found to synergistically inhibit growth when used as a part of a formulation, at even lower concentrations (Cornelison et al. 2014a . There are numerous compounds known to stimulate a positive response, either as a result of a genuine promotion of health or as a result of exposure to a low concentration of a toxin. In the 16th century, Paracelsus, heralded as the father of toxicology, expressed in his Dritte Defensio (1538) that 'all things are poison and nothing is without poison; only the dose makes a thing not a poison.' Indeed, modern toxicology recognizes that virtually all substances display dosedependent effects. This phenomenon of a generally favourable response due to exposure to a low concentration of a toxin or stressor is known in toxicology as hormesis, and this is often the opposite response than that which is observed with higher doses (Southam and Ehrlich 1943) . Although not well-understood, there have been numerous observations of the hormesis phenomenon, suggesting the potential to change how toxicology is understood in relation to risk assessment, study design and dose-response modelling, to name a few (Calabrese and Baldwin 2003) .
Determining the presence of synergistic activity, particularly with noninhibitive or moderately inhibitive compounds, presents significant challenges in the laboratory. As more compounds are added to the testing pool and the number of compounds in the prospective formulation is increased, the number of possible combinations increases dramatically. Furthermore, there are several challenges to developing antimicrobial susceptibility assays when moving from traditional media-based methods to gaseous headspace methods, including the production of airspaces with accurate gaseous concentrations and validation of target airspace concentrations. Therefore, formulation development is often both laborious and unpredictable, requiring extended periods of time to set up each assay and necessitating the testing of all possible combination to discover synergistic inhibitory formulations.
High-throughput methods for identifying and screening gaseous control agents could prove beneficial to disease management initiatives. Although there have been some advancements of methods for high-throughput screening of pathogen control agents (Chaturvedi et al. 2011) and improving protocols for screening control agents (McArthur et al. 2017) , these have primarily focused on contact-dependent exposure methods of control agent inhibition. Potential solutions include automated headspace sampling utilizing solid-phase micro-extraction (HS-SPME) fibres or direct injection sampling for gas-chromatography mass-spectrometry (GCMS) analysis that could identify novel microbially produced compounds. Additionally, in silico modelling could be utilized to predict antagonistic effects of compounds or synergisms in formulation development, with automated robotic assay preparation and analysis pipelines used to confirm and quantify actual effects.
Inhibitory mechanisms
Mechanisms of action should often be explored to determine potential negative toxicological effects, develop methods for increasing effectiveness, and aid in the securement of intellectual property rights. Although the determination of specific mechanisms related to pathogen inhibition or host survivorship is often challenging, it is nonetheless an important aspect to consider. Inhibitory mechanisms will often exploit a particular characteristic shared by a clade of organisms. This also suggests a degree of caution should be taken when developing treatments for fungi, for instance, if the host belongs to the same Eukaryotic domain and may be susceptible to similar deleterious effects.
The body of literature comprising known microbially produced VOCs is numerous (Balis and Kouyeas 1968; Voisard et al. 1989; Caccioni et al. 1997; Gardini et al. 1997; Bruce et al. 2003; Ezra and Strobel 2003; Chuankun et al. 2004; Fernando et al. 2005; Zou et al. 2007; Li et al. 2010; Mitchell et al. 2010; Garbeva et al. 2011; Yuan et al. 2012; Wang et al. 2013; Weisskopf 2013; Cornelison et al. 2014a Cornelison et al. , 2016 Wu et al. 2015; Toffano et al. 2017) . There exists a large number of chemical analogues that may also be potentially effective at eliciting microbial inhibition. The analyses required for determining inhibitory mechanisms often involve in-depth metabolic and genomic study. As a result, only a small portion of known VOCs have been studied to understand specific mechanisms for their inhibition. Prior to our initial investigation to discover the potential of several VOCs to inhibit fungal pathogens (Cornelison et al. 2014a , Weisskopf (2013) observed these compounds eliciting inhibition of germ tube growth (nonanal), mycelial growth (2-ethyl-1-hexanol, benzaldehyde, benzothiazole, and nonanal), pigment production (benzothiazole), and spore germination (2-ethyl-1-hexanol, benzothiazole, and nonanal).
In lieu of direct analysis, possible inhibitory mechanisms may be inferred from the study of the analogues of particular compounds. For instance, benzaldehyde derivatives are known to cause cytoplasmic coagulation or lysis through the disruption of the cellular membrane (Alamri et al. 2012) . Certain azoles have been observed targeting heme-containing proteins, interfering with the production of sterols and leading to the disruption of the plasma membrane, while others were observed inhibiting membrane-bound enzymes or lipid biosynthesis (Ghannoum and Rice 1999) . In many cases, inference of mechanism of action based on known analogues is considered sufficient for product development and regulatory approval when accompanied by sufficient toxicological data. Although far from exhaustive, these potential inhibitory mechanisms of specific antagonists serve as an example of the difficulty of mechanism discovery and demonstrate how relatively little detailed information is known about these compounds.
Biomimicry
Micro-organisms have co-evolved in direct competition and have developed complex mechanisms for effectively producing and disseminating antimicrobial compounds (Hibbing et al. 2010) . Biomimicry enables the use of this time-tested engineering to be applied to other systems and processes. There are several advantages to abstracting the process of disseminating these compounds from the biological source. These include eliminating the time and cost of culturing large quantities of an organism or biological catalyst, eliminating the variability of any potential microbial induction processes, eliminating the possibility of releasing a self-propagating micro-organism into the environment, the ability to modify VOC formulations and compound ratios to enhance effects, the ability to regulate the exact concentration being dispersed, and the ability to regulate the quality of the formulation constituents.
The ubiquitous soil-dwelling bacterium Rhodococcus rhodochrous strain DAP 96253 was initially studied for its ability to inhibit several fungal pathogens, including Pseudogymnoascus destructans, the causative agent of whitenose syndrome (WNS) of bats (Cornelison et al. 2014b) , and Ophidiomyces ophiodiicola, the causative agent of snake fungal disease (SFD) of reptiles . Additionally, several antifungal susceptibility assays with synthetic formulations were conducted with previously discovered antifungal VOCs (Fernando et al. 2005) in order to discover novel antifungal effects against these fungal wildlife pathogens (Cornelison et al. 2014a . However, the safety of these formulations remained to be established, causing concern for their use and necessitating toxicological analyses before conducting experimental treatments. This prompted an investigation to discover effective formulations where safety had previously been established for the chemical constituents.
One potential candidate currently being evaluated in the field for treating WNS is a VOC formulation produced by the endophytic fungus Muscodor crispans strain B-23, a novel isolate from Ananas ananassoides (wild pineapple) from Bolivia. This organism has demonstrated an ability to inhibit several plant and human pathogens by contact-independent antagonism (Mitchell et al. 2008 (Mitchell et al. , 2010 . A synthetic formulation of the gaseous compounds produced by M. crispans strain B-23 has been produced synthetically, which only includes compounds listed by the United States Food and Drug Administration (USFDA) as generally regarded as safe (GRAS, Table 1 ) and has been patented (Strobel et al. 2012) and marketed under the commercial name Flavorzon 185B (Jeneil Biotech, Inc.) (Mitchell et al. 2010 ). This synthetic formulation, further referred to as Flavorzon, has been demonstrated to be safe and of low toxicity, and has been incorporated into several commercial products, for use with multiple mammalian species, agricultural products, and in food preservation. Several qualities of the synthetic Flavorzon formulation make it appealing to use as a control agent, including its ability to inhibit growth of diverse fungal pathogens, and the compounds' inclusion on the USFDA list of GRAS compounds. The developments and commercialization of Flavorzon should serve as a template for how to identify, develop and commercialize antimicrobial VOCs for microbial control applications.
Although volatile-based antimicrobials have routinely been used as a fumigant for controlling pests such as rodents, insects, and micro-organisms, most applications utilize highly hazardous compounds and lack strict concentration control. Because sublethal exposure of a control agent may be sufficient to reduce disease severity or mortality, by regulating the concentration of target-specific compounds to exceed the inhibitory threshold of the pathogen while remaining below the hazardous threshold to the host, there exists the potential to utilize fumigation for disease management. However, development of target-specific compounds, coupled with a cost-effective, scientifically validated distribution system has been lacking.
Distribution system development
A distribution system provides the ability to autonomously attain and maintain a precise target concentration of one or more VOCs and formulations (Fig. 1) . The potential benefits from a target-specific, VOC-based treatment approach include the ability to regulate the exposure concentration in order to negatively impact one organism (pathogen) while not affecting another (host), treat a large area in a short period of time, and treat a large number of organisms without having to handle each individual.
Accordingly, development of a system to disperse accurate gaseous concentrations was undertaken. Several Table 1 The chemical composition of the Flavorzon formulation. The molecular weight, and percentage of the most abundant constituents produced by Muscodor crispans strain B-23, detected using GCMS (Mitchell et al. 2010 Acetic acid, 2-methylpropyl ester 116Á08 0Á56 Propanoic acid, 2-methyl-, 2-methylpropyl ester
aerosolization technologies capable of producing a very fine aerosol were tested for dispersal accuracy, repeatability, resilience to chemical exposure and evaporative efficiency, resulting in a robust system capable of autonomously attaining a precise gaseous concentration in an airspace of a known volume as well as several effective anti-P. destructans VOC formulations . The system utilized off-the-shelf electronic components for the circuit board and is capable of controlling a range of aerosolizers, from medical nebulizers to industrial rotary atomizers. Aerosolization was one of many potential distribution methods chosen for investigation. Table 2 compares several available aerosolization technologies and their differences. Aerosolization is a method of liquid dispersal that facilitates evaporation by the production of microscopic liquid droplets with a high surface area to volume (SA/V) ratio. Evaporation is heavily influenced by surface area, with evaporation time decreasing as surface area increases. A reduction of aerosol droplet size increases the SA/V ratio, increases the total surface area of the liquid volume, and reduces evaporation time.
Different environments and objectives will likely necessitate selection of a technology that is compatible with a number of factors, such as desired droplet size, accessibility of the treatment area, required dispersal volume, Gardini et al. 1997) . Furthermore, the physical environment, such as geology, topology and air flow, may also play a role in affecting these abiotic conditions. Accordingly, each distribution technology may require evaluation with specific compounds or formulations to determine aerosolization rates, in order to develop the programmatic capacity to attain and maintain target concentrations within specific environments. Furthermore, compounds and formulations may require testing under specific environmental conditions and against specific organisms to confirm any desired and undesired effects. The ex situ evaluation of this technology (nebulization) by Kane et al. (2017) with the administration of the antifungal terbinafine to adult cottonmouths (Agkistrodon piscivorus) concluded that effective therapeutic blood concentrations could be achieved for treating SFD. This study is the first of its kind to demonstrate the feasibility of treating SFD and other wildlife mycoses, setting the stage for conducting treatment trials with infected individuals as well as bolstering support for investigating the use of this technology for managing diverse fungal pathogens.
Conclusion
The coevolution of soil microbiota, plant-associated endophytes, and fungal pathogens have produced antagonisms ideally suited for the complex ecology of their environments. The efficacy of low quantities of VOCs suggests the potential of these compounds for in situ application in the treatment and suppression of contamination and disease. Additionally, the development of synergistic formulations supports a theory of soil-based fungistasis as a source of potential control agents, as VOC mixtures are likely responsible for the observed fungistatic activity of many suppressive soils. The typical low level of antimicrobial VOCs produced in natural hosts and the significant antagonistic activity observed at these low levels is promising. The contact-independent activity of antagonistic VOCs has several advantages over topical and oral, contact-dependent, treatment options that have been shown to be effective at inhibiting the growth of pathogens. Contact-independent antagonism allows for the potential treatment of many individuals with a single application and facilitates uniform exposure, lessening the potential for unaffected microbial refugia on the host that may facilitate re-colonization once the inhibitory compound has dissipated or degraded.
The use of volatile formulations for microbial control applications could prove to be a powerful tool for disease management efforts, if effective application methods can be established. Biomimicry has opened the doors to exploring exciting new approaches to solving difficult microbial control challenges. By harnessing novel microorganisms and their natural antagonistic compounds, aerosolization technology has allowed for the development of new tools and techniques for controlling microorganisms with potential to yield a vast number of natural, safe, and patentable formulations that enhance both efficacy and safety.
